Clinical trial

Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy

NCT01175486

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Actos (Pioglitazone) Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Acarbose Normalized identity: acarboseView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-07-01

PhasePHASE4

Conditions

Diabetesverified · MONDO: diabetes mellitus

Interventions

Actos (Pioglitazone)DRUG

AcarboseDRUG · verified · RxNorm: acarbose

Sponsors & collaborators

Taipei Veterans General Hospital, Taiwanlead sponsor

Mapped research locations

TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01175486 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.